Taking a Partial Dose of Wegovy: What Really Happens

What counts as a partial dose, and how does it happen?

The Wegovy pen is pre-filled and pre-set: every injection is designed to deliver one complete dose with a single press and hold. There is no dial, no way to choose half a dose, and no mechanism to top up if something goes wrong mid-injection. A partial dose typically means one of three things happened.

The most common cause is technique. Releasing the pen before the full injection is complete (before the click sounds and the dose window shows the number has moved) leaves some of the medicine under the skin and some still in the pen body. The Wegovy pen's dose window is your clearest signal: if it has not changed fully, the injection was not complete.

The second cause is pen or needle fault. A blocked needle, a damaged seal, or a pen stored incorrectly can prevent proper delivery. Semaglutide must be kept refrigerated; a pen left at room temperature for longer than the Patient Information Leaflet permits may be compromised before you even inject. Worth checking: is your pen sitting in the fridge door where temperatures fluctuate, or on a stable shelf between 2 and 8°C?

The third cause is deliberate reduction, some people reduce their dose to manage nausea. This is understandable, but it changes the pharmacokinetics in ways that are harder to predict than staying on the licensed schedule allows for, and if you want to understand what the programme looks like from the very beginning, our page on the Wegovy starting dose explains how the initial steps are structured before any titration decisions are made. How Wegovy dosing works explains why the titration steps are structured the way they are.

Does a partial dose affect your results or your titration timeline?

One incomplete injection is unlikely to have a measurable clinical effect on weight loss. Semaglutide has a half-life of around one week, so the drug level in your system builds gradually across months, not shifts sharply with a single pen. The STEP 1 trial, published in the New England Journal of Medicine, demonstrated that the average weight loss of around 15% at 68 weeks reflects consistent therapeutic exposure over time, a pattern that one imperfect dose will not break.

What matters more is whether the partial delivery was a one-off or part of a pattern. If your technique is consistently leaving medicine in the pen, your effective dose is lower than your prescription states, and your side-effect profile and results may not track what the clinical evidence predicts. That gap is worth closing, and it is something our clinical team can help with at your next review.

Deliberately keeping doses lower than prescribed for weeks at a time is different again. It may reduce side effects in the short term, but it also means staying at a sub-therapeutic level beyond the window your prescriber planned. The step-up process is calibrated to give your system time to adjust at each strength, not to stay at partial doses indefinitely.

The decision: continue as normal, contact your prescriber, or delay your next dose increase?

If a single partial dose happened because of an identifiable technique error and you are confident you can correct it, continuing with your next scheduled injection is the reasonable choice. Review the injection steps in your Patient Information Leaflet, which gives the authoritative hold-and-count sequence the manufacturer specifies. The NHS semaglutide medicines page also outlines what to do if you miss a dose entirely, a useful reference point for understanding the margin the weekly schedule provides.

Contact your prescriber if: the pen appeared faulty rather than the technique being at fault; you are unsure whether any medicine was delivered; you have had repeated incomplete injections; or you have been deliberately reducing doses and want to discuss whether your current strength is still right for you. A dose increase review at the next scheduled step is the right moment to raise any concerns about tolerability.

If the pen itself was damaged or the delivery looked completely absent, treat it as a missed dose and follow the missed-dose guidance in the Patient Information Leaflet. Do not take two doses in the same week to make up for a missed or partial one, the leaflet is explicit on this point.

For anyone weighing up whether private treatment is the right route to explore these questions with a clinical team, our weight-loss treatment overview sets out what that involves. If you want to understand how the full cost of a supervised private prescription compares with what some providers advertise, the cost context for Wegovy in the UK is worth reading before you decide.